Association Between Insulin Resistance and Myosteatosis Measured by Abdominal Computed Tomography
The Journal of Clinical Endocrinology & Metabolism · 17.11.2023 · 108 (12) · 3100-3110
DOI: 10.1210/clinem/dgad382 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 04.07.2023. Verfasst von Myung Jin Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea. Hauptthemen laut MEDLINE: Abdomen, Insulin Resistance, Muscle, Skeletal. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Context
Ectopic fat deposition in skeletal muscle, termed myosteatosis, is a key factor in developing insulin resistance.
Objective
This work aimed to evaluate the association between insulin resistance and myosteatosis in a large Asian population.
Methods
A total of 18 251 participants who had abdominal computed tomography were included in this cross-sectional study. Patients were categorized into 4 groups according to quartiles of Homeostatic Model Assessment for Insulin Resistance (HOMA-IR). The total abdominal muscle area (TAMA) at the L3 vertebral level was segmented into normal-attenuation muscle area (NAMA), low-attenuation muscle area (LAMA), and intermuscular adipose tissue (IMAT). The absolute values of TAMA, NAMA, LAMA, and IMAT and the ratios of NAMA/BMI, LAMA/BMI, and NAMA/TAMA were used as myosteatosis indices.
Results
The absolute values of TAMA, NAMA, LAMA, and IMAT appeared to increase with higher HOMA-IR levels, and LAMA/BMI showed a similar upward trend. Meanwhile, the NAMA/BMI and NAMA/TAMA index showed downward trends. As HOMA-IR levels increased, the odds ratios (ORs) of the highest quartile of NAMA/BMI and NAMA/TAMA index decreased and that of LAMA/BMI increased. Compared with the lowest HOMA-IR group, the adjusted ORs (95% CI) in the highest HOMA-IR group for the lowest NAMA/TAMA quartile were 0.414 (0.364-0.471) in men and 0.464 (0.384-0.562) in women. HOMA-IR showed a negative correlation with NAMA/BMI (r = −0.233 for men and r = −0.265 for women), and NAMA/TAMA index (r = −0.211 for men and r = −0.214 for women), and a positive correlation with LAMA/BMI (r = 0.160 for men and r = 0.119 for women); P was less than .001 for all.
Conclusion
In this study, a higher HOMA-IR level was significantly associated with a high risk of myosteatosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
- Asan Diabetes Center, Asan Medical Center, Seoul 05505, Republic of Korea.
- Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
ORCID-Profile: Chang Hee Jung, Hong-Kyu Kim, Woo Je Lee
Zitieren
APA
Kim, M. J., Cho, Y. K., Jung, H. N., Kim, E. H., Lee, M. J., Jung, C. H., Park, J. Y., Kim, H. K., & Lee, W. J. (2023). Association Between Insulin Resistance and Myosteatosis Measured by Abdominal Computed Tomography. The Journal of Clinical Endocrinology & Metabolism, 108(12), 3100-3110. https://doi.org/10.1210/clinem/dgad382
Vancouver
Kim MJ, Cho YK, Jung HN, Kim EH, Lee MJ, Jung CH, et al. Association Between Insulin Resistance and Myosteatosis Measured by Abdominal Computed Tomography. The Journal of Clinical Endocrinology & Metabolism. 2023;108(12):3100-3110. doi:10.1210/clinem/dgad382
BibTeX
@article{Kim2023,
author = {Kim, Myung Jin and Cho, Yun Kyung and Jung, Han Na and Kim, Eun Hee and Lee, Min Jung and Jung, Chang Hee and Park, Joong-Yeol and Kim, Hong-Kyu and Lee, Woo Je},
title = {Association Between Insulin Resistance and Myosteatosis Measured by Abdominal Computed Tomography},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {12},
pages = {3100--3110},
doi = {10.1210/clinem/dgad382}
}
EUVIMED